TriSalus Life Sciences: chief commercial officer Richard Marshak sold 325 shares

What happened Richard Marshak, chief commercial officer, sold 325 shares at $4.39 per share on Oct 5, 2026, for $1,427, according to the Form 4 filed on Oct 7, 2026.

Key details

• Transaction date and price: Oct 5, 2026 at $4.39 per share.
• Transaction type/code: open market or private sale (S).
• Shares sold and proceeds: 325 shares; $1,427 realized.
• Footnote F1: the filing states the shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person; "this transaction does not represent a discretionary sale by the Reporting Person."
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Form 4 filed on Oct 7, 2026 (timeliness not indicated in the provided excerpt).

Why it may matter

• The filing indicates the sale was a tax-withholding disposition tied to RSU vesting, not a gift or an option exercise.
• A filing does not show why the insider traded or why the company acted.